Literature DB >> 9736549

Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans.

J M Domínguez1, J J Martín.   

Abstract

The target for sordarins in Candida albicans has been elucidated. Kinetic experiments of sordarin inhibition as well as displacement experiments showed that the formation of a sordarin-target complex follows a reversible mechanism. Binding of tritiated drug to the target is enhanced in the presence of ribosomes. Isolation of the target by classical protein purification methods has allowed us to identify it as elongation factor 2. This is in agreement with the nature of sordarin derivatives as specific inhibitors of the elongation cycle within protein synthesis in yeasts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736549      PMCID: PMC105815          DOI: 10.1128/AAC.42.9.2279

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

Review 1.  Mechanism and regulation of eukaryotic protein synthesis.

Authors:  W C Merrick
Journal:  Microbiol Rev       Date:  1992-06

Review 2.  Protein toxin inhibitors of protein synthesis.

Authors:  J P Perentesis; S P Miller; J W Bodley
Journal:  Biofactors       Date:  1992-01       Impact factor: 6.113

Review 3.  Eukaryotic polypeptide elongation system and its sensitivity to the inhibitory substances of plant origin.

Authors:  W Gałasiński
Journal:  Proc Soc Exp Biol Med       Date:  1996-05

4.  Protein synthesis. An elongation factor turn-on.

Authors:  K H Nierhaus
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

5.  Multiformity of elongation factor eEF-2 isolated from rat liver cells.

Authors:  A Gajko; W Gałasiński; A Gindzieński
Journal:  Biochem Biophys Res Commun       Date:  1994-07-29       Impact factor: 3.575

Review 6.  Peptide-chain elongation in eukaryotes.

Authors:  C G Proud
Journal:  Mol Biol Rep       Date:  1994-05       Impact factor: 2.316

7.  Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts.

Authors:  J M Domínguez; V A Kelly; O S Kinsman; M S Marriott; F Gómez de las Heras; J J Martín
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

8.  Hydrolysis of GTP by elongation factor G drives tRNA movement on the ribosome.

Authors:  M V Rodnina; A Savelsbergh; V I Katunin; W Wintermeyer
Journal:  Nature       Date:  1997-01-02       Impact factor: 49.962

9.  Isolation and characterisation of an antifungal antibiotic (GR135402) with protein synthesis inhibition.

Authors:  O S Kinsman; P A Chalk; H C Jackson; R F Middleton; A Shuttleworth; B A Rudd; C A Jones; H M Noble; H G Wildman; M J Dawson; C Stylli; P J Sidebottom; B Lamont; S Lynn; M V Hayes
Journal:  J Antibiot (Tokyo)       Date:  1998-01       Impact factor: 2.649

10.  Translation elongation factor-3 (EF-3): an evolving eukaryotic ribosomal protein?

Authors:  G P Belfield; N J Ross-Smith; M F Tuite
Journal:  J Mol Evol       Date:  1995-09       Impact factor: 2.395

View more
  31 in total

1.  Three-dimensional cryo-electron microscopy localization of EF2 in the Saccharomyces cerevisiae 80S ribosome at 17.5 A resolution.

Authors:  M G Gomez-Lorenzo; C M Spahn; R K Agrawal; R A Grassucci; P Penczek; K Chakraburtty; J P Ballesta; J L Lavandera; J F Garcia-Bustos; J Frank
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Azasordarins: susceptibility of fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida spp. to GW 471558.

Authors:  M Cuenca-Estrella; E Mellado; T M Díaz-Guerra; A Monzón; J L Rodríguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Domain movements of elongation factor eEF2 and the eukaryotic 80S ribosome facilitate tRNA translocation.

Authors:  Christian M T Spahn; Maria G Gomez-Lorenzo; Robert A Grassucci; Rene Jørgensen; Gregers R Andersen; Roland Beckmann; Pawel A Penczek; Juan P G Ballesta; Joachim Frank
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

Review 4.  An insight into the antifungal pipeline: selected new molecules and beyond.

Authors:  Luis Ostrosky-Zeichner; Arturo Casadevall; John N Galgiani; Frank C Odds; John H Rex
Journal:  Nat Rev Drug Discov       Date:  2010-08-20       Impact factor: 84.694

5.  Improvement of sordarin production through process optimization: combining traditional approaches with DOE.

Authors:  Thomas P Tully; James S Bergum; Steven R Schwarz; Susan C Durand; Jeffrey M Howell; Ramesh N Patel; Paul M Cino
Journal:  J Ind Microbiol Biotechnol       Date:  2006-11-28       Impact factor: 3.346

6.  Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.

Authors:  Yasuki Kamai; Masayo Kakuta; Takahiro Shibayama; Takashi Fukuoka; Shogo Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

7.  Purification, crystallization and preliminary X-ray analysis of adenylosuccinate synthetase from the fungal pathogen Cryptococcus neoformans.

Authors:  Ross D Blundell; Simon J Williams; Carl A Morrow; Daniel J Ericsson; Bostjan Kobe; James A Fraser
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-08-21

8.  Antifungal activities and cytotoxicity studies of six new azasordarins.

Authors:  E Herreros; M J Almela; S Lozano; F Gomez de las Heras; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi.

Authors:  E Herreros; C M Martinez; M J Almela; M S Marriott; F G De Las Heras; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  A chemical genomic screen in Saccharomyces cerevisiae reveals a role for diphthamidation of translation elongation factor 2 in inhibition of protein synthesis by sordarin.

Authors:  Javier Botet; María Rodríguez-Mateos; Juan P G Ballesta; José Luis Revuelta; Miguel Remacha
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.